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Background: Management of indeterminate pulmonary nodules (IPN) in colorectal cancer (CRC) is
challenging, with no clear guidance for management. We aimed to study whether certain patient and
disease based factors can be used to give guidance about further investigation, treatment and outcome of
these lesions.
Methods: Data was collected via a 2-year retrospective case-note review of patients discussed at the
multi-disciplinary meeting with a conﬁrmed diagnosis of CRC and IPN on CT scan. Further studies were
identiﬁed by a Pubmed search with no limitations and a review of references within those papers. Pooled
analysis was performed where the data was available.
Results: Over the two year period, 539 new cases of CRC were discussed locally. Of these, 28 (5.2%) were
found to have IPN. Malignancy was more likely when multiple nodules were detected at presentation
(p < 0.05). Pooled analysis of a further 7 studies was performed where data was available. This conﬁrmed
the signiﬁcance of multiple nodules in terms of predicting malignancy (p < 0.01) and additionally
demonstrated the signiﬁcance of nodal disease (p < 0.01).
Conclusion: This study demonstrates the difﬁculties of determining the nature of IPN using either patient
or tumour characteristics. Signiﬁcant factors appear to be the presence of multiple nodules and nodal
disease. In such cases we recommend further imaging at time of detection. If absent, we recommend an
interval CT scan at six months.
 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Colorectal cancer (CRC) is the third most commonly diagnosed
cancer, following breast and lung. Rates are stable, with 32,800 new
diagnoses in 2009 and an age standardised incidence of 56 males
and 36 females per 100,000 population in the UK.1 Current NICE
guidance recommends that all patients are offered a staging CT scan
of the chest, abdomen and pelvis to detect metastatic disease,
which is found in approximately 25% at presentation.2,3 The
sensitivity/speciﬁcity of computed tomography for picking up
extra-hepatic metastases is 60.9%/91% respectively on a per lesion
basis.2 However, the optimal strategy for staging, particularly of the
chest, is the subject of much debate. A recent review4 concluded
that the clinical signiﬁcance of the increased detection rate of CT of
indeterminate pulmonary nodules (IPN) and pulmonary metas-
tases was unclear, and make it clear that further work into the
optimal imaging strategy of the chest is much needed.fﬁths).
ciates Ltd. Published by Elsevier LtThe identiﬁcation of metastatic disease is important at all stages
of cancer treatment, in terms of both impact on best treatment of
the primary as well as that of the metastatic deposit.2 However,
characterisation of the morphological features of small nodules
detected by CT scan is difﬁcult, meaning a signiﬁcant proportion is
labelled as indeterminate.Whilst most IPN are those too small to be
characterised, there are some larger nodules which fail to demon-
strate either speciﬁc benign or malignant characteristics and are
therefore also unable to be classiﬁed.5
Though the importance of IPN in colorectal cancer is becoming
more apparent, there is still little consensus in the literature on
their signiﬁcance. Reported rates are variable, with estimates of 4e
43%.6e12 The vast majority are benign, however there is little
evidence for or review of best practice with regards to manage-
ment. Issues of debate include the use of further imagingmodalities
at the time of detection, interval scans and chemotherapy.
We aimed to study whether certain patient and disease based
factors can be used to give guidance about further investigation,
treatment and outcome of IPN in CRC, in the hope of standardising
management to optimise outcomes and better target resources.
Furthermore, because of the small patient numbers involved, wed. All rights reserved.
Table 2
Tumour characteristics in patients with indeterminate lung lesions.
Malignant n ¼ 7 Non-malignant n ¼ 17
T status
T1 0 0
T2 0 4
T3 5 6
T4 2 7
N status
N0 2 8
N1 4 6
N2 1 3
Dukes
A 0 3
B 2 5
C 5 9
Grade
1 0 0
2 7 13
3 0 4
LN status
All negative 3 9
1 positive 4 8
EMVI
Negative 5 10
S.N. Grifﬁths et al. / International Journal of Surgery 10 (2012) 575e577576
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pooled analysis where possible.
2. Methods
Data was collected via a 2-year retrospective case-note review of 539 patients
discussed at the multi-disciplinary meeting with a conﬁrmed diagnosis of CRC
throughout 2009e2010. Patients whowere unﬁt to undergo any procedure to obtain
a conﬁrmed tissue diagnosis of CRC were excluded from the study. A staging CT of
the chest and abdomen was performed in all patients, which identiﬁed 28 patients
with indeterminate pulmonary nodules as per consultant radiologist report. All
patients were scanned with 64 or 4 slice Toshiba Aquillion scanners. Contrast-
enhanced or high resolution scans were performed as deemed most appropriate
by the supervising radiologist.
Variables were recorded with regards to the patient (age, presentation, ASA,
CEA), IPN (size, site, number) and tumour (number of affected nodes, EMVI (extra-
mural vascular invasion) status, TNM, Duke’s staging), as well as other imaging
undertaken and outcome. Data was analysed using non-parametric tests (Manne
Whitney and c2).
The Pubmed database was searched for published articles looking at IPN in CRC.
No limitations were applied to the search. Studies including other primary malig-
nancies as well as colorectal cancer were excluded. Seven studies were identiﬁed
which contained details of incidence of IPN and progression to metastases,6e12 of
which four6e9 contained further details allowing pooled analysis of results. Data
collected was analysed using the independent KruskaleWallis test.Positive 2 7
Other metastases at presentation
Hepatic 3 0
Extra-hepatic 0 03. Results
Over the two year period of 2009e2010, 539 new cases of
colorectal cancer were discussed at the local multi-disciplinary
meeting. Of these, 28 patients (5.2%) had indeterminate pulmonary
nodules, of which 9 (32.1%) subsequently developed into conﬁrmed
metastatic deposits (median follow-up 370 days). The median
length of time to diagnosis of IPN as metastatic was 245 days. As
such, each patient was treated in accordance with their remaining
disease status, with 24 of 28 patients (85.7%) undergoing surgical
resection of the primary tumour. Table 1 shows the characteristics
of the patients who developed metastatic disease in comparison
with those who did not. Patients who had multiple IPN on CT were
at higher risk of developing metastatic disease (p < 0.05) Table 2
shows tumour characteristics in the 24 who underwent surgical
resection of the primary tumour, again comparing those who
developed metastatic disease to those who did not. Of the 6
patients who underwent further imaging at the time of detection of
the lesion, all were able to be characterised, with 5 malignant and 1
benign. All of these patients had PET scans. Of the nine patients who
had IPN conﬁrmed as metastatic disease, one underwent wedge
resection.Table 1
Characteristics of patients with indeterminate lung lesions.
Malignant
n ¼ 9
Non-malignant
n ¼ 19
Age, completed years,
median (range)
65 (55e89) 67 (28e82)
Presentation
Symptomatic 8 17
Asymptomatic 1 2
ASA
ASA 1 1 2
ASA 2 7 13
ASA 3 1 4
CEA at presentation,
median (range)
4 (<1e58) 1 (<1e49)
Size of largest nodule, mm,
mean (range)
6.3 (4e9) 5.8 (2e14)
Number of nodulesa
Single 1 10
Multiple 8 9
a statistically signiﬁcant difference (p < 0.05).Table 3 demonstrates ﬁndings of the identiﬁed studies along
with our own results. A total of 2991 patients were included, with
345 identiﬁed as having indeterminate pulmonary nodules (11.5%),
of which 60 (17.4%) were conﬁrmed as metastatic deposits of
colorectal cancer. Individual studies were able to demonstrate
some signiﬁcant associations. Brent et al.6 recommend the use of
nodal disease as an indicator of increased likelihood of malignancy,
with all (5/5) metastatic deposits associated with N1 or N2 disease,
as opposed to 13 of the 19 patients (70%) whose lesions were
conﬁrmed as benign. No report of statistical signiﬁcance is made
and no other variables are given in the paper. Christoffersen et al.7
found a signiﬁcant association with positive nodal disease
(p < 0.05), as well as post-operative CEA elevation. Quyn et al.8
found an association between number of nodules (>4) and
increased likelihood of malignancy (p < 0.01). Mathiel et al.9 used
regression analysis to demonstrate only that the presence of
calciﬁcation within the pulmonary nodule reduced the likelihood
of malignancy. No signiﬁcance was found in any other variable,
including nodule number. Nodal disease was not discussed. Three
further studies10e12 did not record any further variables but were
simply an assessment of the incidence of IPNs.
Pooled analysis was performed using the independent Kruskale
Wallis test. No signiﬁcance was found in terms of T status or theTable 3
Overview of included studies.
Study Total
patients
No. IPNs % IPNs No. conﬁrmed
metastatic
deposits
% IPN
conﬁrmed
metastatic
deposits
Local 539 28 5.2 9 32.1
Brent et al. 439 45 10.3 5 11.1
Christofferson et al. 131 26 19.8 6 23.1
Quyn et al. 908 37 4.1 8 21.6
Mathiel et al. 160 68 42.5 24 35.3
Grossmann et al. 200 50 25.0 8 16.0
Kronawitter et al. 202 60 29.7 0 0
Walter et al. 412 31 7.5 0 0
Totals 2991 345 11.5 60 17.4
Table 5
Pooled analysis of nodule number.
Malignant n ¼ 17 Non-malignant n ¼ 48
Singlea 3 28
Multiplea 14 20
a statistically signiﬁcant difference (p ¼ 0.004).
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disease present, comparing N0eN1 or N2 disease as per the avail-
able data (p ¼ 0.001, Table 4). Signiﬁcance was also again found in
the number of nodules detected, with multiple nodules at higher
risk of metastatic disease (p ¼ 0.004, Table 5).
4. Discussion
This study and review of the literature highlights the difﬁculties
of managing indeterminate pulmonary nodules and predicting
likely outcomes, based on patient, nodule or tumour characteristics.
A further difﬁculty is the lack of consensus on classiﬁcation of IPN.
Generally, it is those nodules which are too small to evaluate on
radiological characterisation such as density and shape. Of the
studies reviewed, only one described the characteristics of an
indeterminate nodule.8 This took its deﬁnition as an incidental soft
tissue opacity with no calciﬁcation within the lung parenchyma.
Fleischner Society guidelines5 also highlight the difﬁculties of
deﬁning IPN, before setting out the pathological deﬁnition as
a “small, approximately spherical, circumscribed focus of abnormal
tissue” and the radiologic deﬁnition as a “round opacity, at least
moderately well marginated and no greater than 3 cm inmaximum
diameter”. These rather non-speciﬁc descriptions give radiologists
little support in making their diagnosis. Other characteristics which
can be considered in the differentiation between benign and
malignant nodules include patterns of calciﬁcation, fat content and
solid versus non-solid appearance.
Fleischner Society guidelines5 also aim to set out a clear
management plan for IPN based on risk of malignancy. They deem
relevant factors to be size of nodule and generic patient risk factors
for malignancy versus infection, including age, nodule number,
unexplained fever and a distant primary malignancy. Results from
our data sets however are not in agreement with these, with no
signiﬁcance found with regards to nodule size and the presence of
multiple nodules being a risk factor for malignancy as opposed to
indicating an increased likelihood of infectious origin as suggested.
It is important to note that the bulk of research that was taken into
account whilst deﬁning these guidelines was largely obtained from
lung cancer screening programs. It is difﬁcult to know if these can
be directly extrapolated to IPN with a conﬁrmed primary extra-
thoracic malignancy. The differences between the factors we
consider to be risks for metastases and those the guidelines
consider signiﬁcant suggest this extrapolation is not suitable, and
that more speciﬁc guidance is required speciﬁcally with regard to
IPN in association with extrathoracic malignancy.
There are some limitations of this review due to the nature of
studies involved. For example, Mathiel et al.9 included all sub-
centimetre nodules in a cohort of patients who had conﬁrmed
resectable hepatic metastases, suggesting a primary tumour that
was more aggressive in nature. Furthermore, pooled analysis of
results was difﬁcult due to limited data being presented, meaning
group sizes remain small. However, where possible this analysis
demonstrates the signiﬁcance of multiple nodules and nodal
disease in terms of outcome of the IPN.Table 4
Pooled analysis of N status.
Malignant n ¼ 26 Non-malignant n ¼ 79
N0a 2 37
N1 11 14
N2 8 9
N1/2 4 13
Total N1/2a 24 42
a statistically signiﬁcant difference (p ¼ 0.001).We propose a management pathway encouraging the use of
alternative imaging modalities when risk factors for metastasis are
present. The use of interval scans should be encouraged where risk
factors are not present. We consider these risk factors to be the
presence of more than one nodule and/or nodal disease (N1 or N2).
PET is an appropriate alternative imaging modality for pulmonary
disease, with all lesions in our own cohort being characterised with
the use of PET when available. Other modalities, such as PET/CT,
may also become appropriate when available. Further imaging
should also be performed where there is any hint of progression of
disease and the patient is considered ﬁt for surgical intervention.
However, the low rate of conﬁrmation of metastatic disease from
these IPN highlight that their detection should not alter manage-
ment of the primary tumour.
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